about
Bed occupancy rates and hospital-acquired infections--should beds be kept empty?STROBE-AMS: recommendations to optimise reporting of epidemiological studies on antimicrobial resistance and informing improvement in antimicrobial stewardshipExposure to low doses of Coxiella burnetii caused high illness attack rates: Insights from combining human challenge and outbreak data.Human dose response relation for airborne exposure to Coxiella burnetiiPerformance of Kiestra total laboratory automation combined with MS in clinical microbiology practiceInflux of multidrug-resistant organisms by country-to-country transfer of patients.Pseudobacteremia outbreak of biofilm-forming Achromobacter xylosoxidans - environmental transmission.Detection of a cfr(B) Variant in German Enterococcus faecium Clinical Isolates and the Impact on Linezolid Resistance in Enterococcus spp.Susceptibility of multidrug resistant clinical pathogens to a chlorhexidine formulationInfection Risk in Sterile Operative Procedures.Sources of systematic errors in the epidemiology of vancomycin-resistant enterococci.Device-related infections in long-term healthcare facilities: the challenge of prevention.Prosthetic joint infections in the elderly.Education in infection control: A need for European certification.Minimum requirements in infection control.Controversies in guidelines for the control of multidrug-resistant Gram-negative bacteria in EU countries.The relationship between subjective perception and the psychological effects of patients in spatial isolationHyaluronan-mediated mononuclear leukocyte binding to gingival fibroblasts.Increased frequency of linezolid resistance among clinical Enterococcus faecium isolates from German hospital patients.Use of evidence-based recommendations in an antibiotic care bundle for the intensive care unit.Sterility Testing of Injectable Products: Evaluation of the Growth-based BacT/ALERT® 3D™ Dual T Culture System.Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures.Evaluation of the scientific impact of the Ebola epidemic: a systematic review.Natural isothiocyanates express antimicrobial activity against developing and mature biofilms of Pseudomonas aeruginosa.Corrigendum to 'Costs and possible benefits of a two-tier infection control management strategy consisting of active screening for multidrug-resistant organisms and tailored control measures' [Journal of Hospital Infection 93 (2016) 191-196].Improvement of infection control management by routine molecular evaluation of pathogen clusters.Comparative testing of disinfectant efficacy on planktonic bacteria and bacterial biofilms using a new assay based on kinetic analysis of metabolic activity.Improvement of Hand Hygiene Quality and Compliance Using Bioburden Measurement and Online Feedback in Germany.Comparison of livestock-associated and health care-associated MRSA-genes, virulence, and resistance.Determinants for persistence of Pseudomonas aeruginosa in hospitals: interplay between resistance, virulence and biofilm formation.Activity of temocillin, mecillinam, ceftazidime, and ceftazidime/avibactam against carbapenem-non-susceptible Enterobacteriaceae without carbapenemase production.[Treatment options for serious infections caused by vancomycin-resistant enterococci].Low risk of apparent transmission of vancomycin-resistant Enterococci from bacteraemic patients to hospitalized contacts.Ischaemic intestinal perforation complicated by Clostridium perfringens sepsis in a diabetic patient.Is your antiseptic effective against clinical multidrug-resistant microorganisms? A chlorhexidine digluconate formulation demonstrates efficacy even in lower concentrations.Antimicrobial consumption and impact of antimicrobial stewardship programmes in long-term care facilitiesTreating urinary tract infections due to MDR E. coli with Isothiocyanates – a phytotherapeutic alternative to antibiotics?Infection prevention and control in Europe – the picture in the mosaicVancomycin-resistente Enterokokken: Erhöhte Sterblichkeit durch Tigecyclin?In-hospital costs of community-acquired colonization with multidrug-resistant organisms at a German teaching hospital
P50
Q26863729-68FCBC73-DFB6-41D9-B8F3-C4402111E427Q28067215-F340D711-CAA4-4874-875D-58D86FF7BCB1Q30952511-4F3768DF-BFC6-4417-B7BE-EB4A22220779Q35020570-42E2A1B5-2D35-45A4-9144-88C41DBB9FA9Q35119444-F985E5DA-8394-4908-B924-65F13497C5FDQ35823726-5A92F74C-0C55-4A70-B692-2C2B76A28785Q36166643-A5A68623-D6F7-4218-A411-05B6D5072609Q36205566-0D1B8E7E-E442-414B-AC26-209E62BFE06CQ36580707-E6FE2A51-FEC1-400B-86AB-07C191984941Q37176640-32B5708C-0573-459F-867C-793C3522A030Q38079537-330B0E1A-92D2-4299-B3DD-2830878B85A6Q38210322-39036F35-D905-4022-BD14-32521E487CA5Q38533911-388374B1-FE9D-4ADC-9960-04963C69E3D2Q38585509-67B0F16E-3AE4-45CA-B0B8-D1B57DBC4226Q38585513-1116C4F8-E14B-42ED-A05F-E04843CC98C1Q38598992-08F39964-33B7-4109-A58D-1B26B7832F96Q38608908-5F43C1F8-3A3B-49A6-BD4D-C932ED1DE3BEQ38628038-0D637EA8-7534-49DD-8C97-5A1DCC7BCAD2Q39164932-9C6F956A-BD74-4CF0-B40F-C36C7D7C0FCAQ39433584-6466B4A4-6145-45F9-B18C-CF5A420C44AEQ39668245-8AF87854-BFE3-4CC0-821F-AB7CCE7D4871Q39823947-BE5EC931-0F1E-41E3-A3AB-F8CF4E777BA4Q40040172-C5036F65-0E22-4511-A9A9-EF93DC9B832CQ40259298-3ABEF9AA-ED98-4A8B-A05C-808A082753B3Q40289822-3BE9090D-7EB7-4C4B-BE21-473A8208E74FQ40336226-24E2D7BC-36EE-4A89-9606-2C05AF137268Q40443023-8EC40020-7011-4581-99BC-0904537F00D1Q40462269-E0364ADD-7934-4019-AB51-CA56478DD015Q40466769-070A3A1A-BBF9-4B73-B8E7-AADFBE1C83F1Q40508725-F6BF04BE-C2D2-4F0D-85B9-4E6E7F608048Q40967518-8CDC0480-B626-4CFA-93CB-3247D48D331BQ41549518-F40C6245-F4C7-473C-B8F6-1418424D5359Q42272830-34D881AA-31EF-4D94-B39D-2C27FF6465A4Q44238619-6848B3AE-5DFD-44EC-BFFB-023A984DC184Q46036850-2C56E2EA-9BCF-4875-B0A0-07AB4E3726EFQ57171109-096DAD73-093C-4DCB-BE65-EE7339D0DC5CQ57643496-7738CC66-C113-453D-918E-CFA47922BAA3Q57643535-1A484322-DA4D-4CBC-B1B2-7F34AC1D44F7Q57643540-AD9CE7A9-4243-4349-8EBE-2356EF37C51CQ58695105-4BFB604A-ED3A-413D-92BC-DC2BAB825DDB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
taighdeoir
@ga
հետազոտող
@hy
name
Nico T Mutters
@ast
Nico T Mutters
@en
Nico T Mutters
@es
Nico T Mutters
@sl
type
label
Nico T Mutters
@ast
Nico T Mutters
@en
Nico T Mutters
@es
Nico T Mutters
@sl
prefLabel
Nico T Mutters
@ast
Nico T Mutters
@en
Nico T Mutters
@es
Nico T Mutters
@sl
P214
P227
P101
P1053
B-5287-2013
P106
P19
P21
P213
0000 0000 5741 4766
P214
P227
P31
P3829
P496
0000-0002-0156-9595
P569
1980-01-01T00:00:00Z
P734
P735
P7859
viaf-81126799